Patients with diabetic retinopathy given ranibizumab have less need for PRP

• Posted on: Jan 20 2022
• By: Saratoga Opthalmology
• Leave a response

Investigators conducted a post hoc analysis evaluating panretinal photocoagulation (PRP) treatment and re-treatment patterns in the Phase 3 randomized, controlled RIDE and RISE trials of ranibizumab.
Source: AAO

Posted in: Uncategorized